Efficacy of bi-monthly hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma

about

Efficacy of bi-monthly hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma

Item

http://www.wikidata.org/entity/Q58806056

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Efficacy of bi-monthly hepatic ...... anced hepatocellular carcinoma

@en

Efficacy of bi-monthly hepatic ...... anced hepatocellular carcinoma

@nl

type

Item

label

Efficacy of bi-monthly hepatic ...... anced hepatocellular carcinoma

@en

Efficacy of bi-monthly hepatic ...... anced hepatocellular carcinoma

@nl

prefLabel

Efficacy of bi-monthly hepatic ...... anced hepatocellular carcinoma

@en

Efficacy of bi-monthly hepatic ...... anced hepatocellular carcinoma

@nl

P1476

Efficacy of bi-monthly hepatic ...... anced hepatocellular carcinoma

@en

P2093

Akira Mitoro

http://www.w3.org/2001/XMLSchema#string

Akitoshi Douhara

http://www.w3.org/2001/XMLSchema#string

Hideto Kawaratani

http://www.w3.org/2001/XMLSchema#string

Hiroaki Takaya

http://www.w3.org/2001/XMLSchema#string

Hitoshi Yoshiji

http://www.w3.org/2001/XMLSchema#string

Junichi Yamao

http://www.w3.org/2001/XMLSchema#string

Kei Moriya

http://www.w3.org/2001/XMLSchema#string

Kenichiro Seki

http://www.w3.org/2001/XMLSchema#string

Kosuke Kaji

http://www.w3.org/2001/XMLSchema#string

Masanori Furukawa

http://www.w3.org/2001/XMLSchema#string

P2860

JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

Sorafenib in advanced hepatocellular carcinoma

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma.

Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolization.

Concurrent partial splenic embolization with transcatheter arterial chemoembolization for hepatocellular carcinoma can maintain hepatic functional reserve.

Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy.

Feasibility and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma after sorafenib.

P304

741-749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JGO.2018.05.13

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30151271

http://www.w3.org/2001/XMLSchema#string

P921

gastroenterology

chemotherapy

P932

6087873

http://www.w3.org/2001/XMLSchema#string